METROPOLIS - Swing Trade Analysis with AI Signals
Back to ListHere’s the structured swing trade analysis for Metropolis Healthcare (METROPOLIS) based on the provided parameters
Swing Trade Rating: 3.5
| Stock Code | METROPOLIS | Market Cap | 11,246 Cr. | Current Price | 542 ₹ | High / Low | 600 ₹ |
| Stock P/E | 69.0 | Book Value | 67.0 ₹ | Dividend Yield | 0.37 % | ROCE | 15.9 % |
| ROE | 12.4 % | Face Value | 2.00 ₹ | DMA 50 | 514 ₹ | DMA 200 | 490 ₹ |
| Chg in FII Hold | -1.25 % | Chg in DII Hold | 1.07 % | PAT Qtr | 43.3 Cr. | PAT Prev Qtr | 38.0 Cr. |
| RSI | 57.1 | MACD | 6.51 | Volume | 2,53,027 | Avg Vol 1Wk | 2,97,994 |
| Low price | 412 ₹ | High price | 600 ₹ | PEG Ratio | 12.7 | Debt to equity | 0.13 |
| 52w Index | 69.4 % | Qtr Profit Var | 82.6 % | EPS | 7.60 ₹ | Industry PE | 47.4 |
📊 Metropolis is trading at ₹542, above both 50 DMA (₹514) and 200 DMA (₹490), showing short-term strength. RSI at 57.1 indicates neutral-to-positive momentum, while MACD (6.51) confirms bullish bias. Volumes (2.53L) are slightly below weekly averages (2.97L), suggesting reduced participation. Valuations are expensive (P/E 69.0 vs industry 47.4), supported by EPS of ₹7.60. Fundamentals remain moderate with ROCE (15.9%) and ROE (12.4%). Quarterly PAT improved (₹38.0 Cr → ₹43.3 Cr, +82.6%), though PEG ratio at 12.7 suggests costly growth. Debt-to-equity is low at 0.13, ensuring financial stability.
💡 Optimal Entry: ₹520–₹530 (near 200 DMA support zone)
🚪 Exit if Holding: Profit-taking zone around ₹580–₹590; Stop-loss below ₹510
✅ Positive
- Trading above both 50 DMA and 200 DMA
- Quarterly PAT growth (+82.6%)
- Low debt-to-equity ratio (0.13)
- DII holdings increased (+1.07%)
⚠️ Limitation
- High valuation (P/E 69.0 vs industry 47.4)
- PEG ratio at 12.7 indicates expensive growth
- Volumes below weekly average
- FII holdings decreased (-1.25%)
📉 Company Negative News
- Reduced foreign institutional participation
- Valuation premium limits upside potential
📈 Company Positive News
- Quarterly PAT improved significantly
- Domestic institutional inflows (+1.07%)
🏭 Industry
- Diagnostics sector average P/E at 47.4, Metropolis trades at a premium (P/E 69.0)
- Sector outlook remains strong with rising demand for healthcare services
🔎 Conclusion
Metropolis Healthcare is a cautious swing trade candidate. Entry near ₹520–₹530 offers controlled risk, while exits should be considered around ₹580–₹590. Strong PAT growth and DII inflows provide positives, but stretched valuations and FII outflows suggest traders should remain disciplined with stop-losses.
Would you like me to extend this into a peer comparison with other diagnostic players like Dr. Lal PathLabs or KIMS, or refine it into intraday trading levels for sharper execution?